Skinvisible Reports Licensee Success in Netherton Syndrome Clinical Studies
Go back to Skinvisible Reports Licensee Success in Netherton Syndrome Clinical Studies| (NASDAQ: QNRX) | Delayed: 8.67 +0.10 (1.17%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.57 | 52 Week High | $ | |||
| Open | $8.74 | 52 Week Low | $ | |||
| Day High | $8.97 | P/E | N/A | |||
| Day Low | $8.46 | EPS | $ | |||
| Volume | 13,042 | |||||
| Skinvisible, Inc. (AMEX: SKVI) | Delayed: 0.38 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.38 | 52 Week High | $0.04 | |||
| Open | $0.38 | 52 Week Low | $0.00 | |||
| Day High | $0.38 | P/E | N/A | |||
| Day Low | $0.38 | EPS | $-0.01 | |||
| Volume | 5,947,103 | |||||
